Amarasate, the patented active ingredient in Calocurb, was developed in New Zealand over 13 years and with $30m invested by Plant and Food Research, the largest NZ government-owned research institute
Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970
Primary markers include IGF-1, fasting insulin, and targeted metabolomic panels evaluating oxidative phosphorylation byproducts
When glutathione levels are low, deiodinase activity is impaired, potentially reducing T4-to-T3 conversion and contributing to symptoms of hypothyroidism even when TSH and T4 levels appear normal - a pattern frequently reported by patients with Hashimoto's thyroiditis
"There is not much long term data on chronic use of GLP-1s." What are GLP-1 drugs
Patients with thyroid conditions should discuss this thoroughly with their healthcare provider before considering any GLP-1 therapy, including microdosing